The Sainsbury Laboratory, Norwich NR4 7UH, United Kingdom.
Plant Cell. 2012 Oct;24(10):4205-19. doi: 10.1105/tpc.112.100263. Epub 2012 Oct 19.
The activity of surface receptors is location specific, dependent upon the dynamic membrane trafficking network and receptor-mediated endocytosis (RME). Therefore, the spatio-temporal dynamics of RME are critical to receptor function. The plasma membrane receptor flagellin sensing2 (FLS2) confers immunity against bacterial infection through perception of flagellin (flg22). Following elicitation, FLS2 is internalized into vesicles. To resolve FLS2 trafficking, we exploited quantitative confocal imaging for colocalization studies and chemical interference. FLS2 localizes to bona fide endosomes via two distinct endocytic trafficking routes depending on its activation status. FLS2 receptors constitutively recycle in a Brefeldin A (BFA)-sensitive manner, while flg22-activated receptors traffic via ARA7/Rab F2b- and ARA6/Rab F1-positive endosomes insensitive to BFA. FLS2 endocytosis required a functional Rab5 GTPase pathway as revealed by dominant-negative ARA7/Rab F2b. Flg22-induced FLS2 endosomal numbers were increased by Concanamycin A treatment but reduced by Wortmannin, indicating that activated FLS2 receptors are targeted to late endosomes. RME inhibitors Tyrphostin A23 and Endosidin 1 altered but did not block induced FLS2 endocytosis. Additional inhibitor studies imply the involvement of the actin-myosin system in FLS2 internalization and trafficking. Altogether, we report a dynamic pattern of subcellular trafficking for FLS2 and reveal a defined framework for ligand-dependent endocytosis of this receptor.
表面受体的活性具有位置特异性,依赖于动态膜运输网络和受体介导的内吞作用(RME)。因此,RME 的时空动力学对于受体功能至关重要。质膜受体 flagellin 感应 2(FLS2)通过感知 flagellin(flg22)赋予细菌感染的免疫性。在引发后,FLS2 被内化到小泡中。为了解决 FLS2 运输问题,我们利用定量共聚焦成像进行共定位研究和化学干扰。FLS2 通过两种不同的内吞运输途径定位到真正的内体,具体取决于其激活状态。FLS2 受体以 Brefeldin A(BFA)敏感的方式组成性地循环,而 flg22 激活的受体通过 ARA7/Rab F2b-和 ARA6/Rab F1-阳性内体运输,对 BFA 不敏感。FLS2 内吞作用需要功能性 Rab5 GTPase 途径,这是通过显性负性 ARA7/Rab F2b 揭示的。Concanamycin A 处理增加了 flg22 诱导的 FLS2 内体数量,但 Wortmannin 减少了该数量,表明激活的 FLS2 受体被靶向到晚期内体。RME 抑制剂 Tyrphostin A23 和 Endosidin 1 改变但没有阻断诱导的 FLS2 内吞作用。进一步的抑制剂研究表明,肌动球蛋白系统参与 FLS2 的内化和运输。总的来说,我们报告了 FLS2 的亚细胞运输动态模式,并揭示了该受体配体依赖性内吞作用的明确框架。